Skip to main content
. 2023 Dec 21;19(10):2157–2174. doi: 10.4103/1673-5374.391179

Figure 6.

Figure 6

IMPs might ameliorate acute brain edema and lower intracranial pressure to provide neuroprotection.

(A)The quantitative magnetic resonance imaging R2* sequence and the total amount of R2* hyperintense volume of vehicle- and IMP-treated groups. (B) Quantitative analysis of the ventricular volumes in the groups that received IMP and the vehicle. Reprinted from Sharma et al. (2020) with permission from John Wiley and Sons. IMPs: Immunomodulatory nanoparticles.